About a year after ScanWatch received regulatory approval in Europe, and Withings eventually received FDA approval for the wearable’s EKG and SpO2 monitoring functions.
Customers in the United States can now use the ECG feature to detect atrial fibrillation (AFib). The watch is designed to alert users to suspected AFib. Users can then take a 30-second EKG measurement with the tool.
The new clearance also enables SpO2 monitoring, which can be used to check the level of oxygen in the blood. According to the company, this measure can help identify respiratory diseases such as COPD or COVID-19. The watch is also equipped with an algorithm that analyzes blood oxygen levels, heart rate, movement and breathing rate in order to pinpoint nocturnal breathing disorders that are an indicator of sleep apnea.
As with previous Withings watches, the tool can also be used to monitor their heart rate, sleep and heart rate during fitness activities. The company plans to launch the device in North America in November, charging $ 279 for the tool.
THE BIGGER TREND
according to CDC, AFib is the most common type of arrhythmia. By 2030, the agency estimates that 12.1 million people in the United States will have the disease. Atrial fibrillation can increase a patient’s risk of stroke.
However, according to the CDC, the condition can be treated with medication and lifestyle changes.
Sleep apnea is a common condition in the United States, too, According to the Sleep Foundation, it is estimated that between 2% and 9% of adults in the United States have the condition. The condition is a risk factor for cardiovascular problems like high blood pressure, heart attack, and heart disease.
“ScanWatch has been clinically validated to detect AFib and can help identify breathing disorders, which can be signs of breathing problems like COPD and sleep apnea. It is our most ambitious medical watch to date and has the potential to be used by millions of people. ” Withings CEO Mathieu Letombe said in a statement.
THE BIGGER TREND
In 2018, Apple The Series 4 Apple Watch was the first FDA-approved wearable with EKG capabilities. This was the start of the wearable race for an EKG function. Just over a year ago, Fitbit received regulatory approval in the US and EU for its Fitbit Sense smartwatch to monitor heart rate and detect atrial fibrillation.
In January, Samsung announced the introduction of its blood pressure measurement and EKG monitoring on its smartwatches.
The public got the first look at the ScanWatch back inJanuary 2020. Last month, the company announced the launch of the ScanWatch Horizon, which combines heart health features with a luxury watch look. However, the watch is only available in France, the UK and Germany.